Search

Showing "11154" results for ""

International AIDS Vaccine Initiative abandons lead vaccine candidate, citing poor responses

Merck's Ad5 is AIDS vaccine most likely to test concept

Measles vaccine proposed for global AIDS protection

WHO issues guidance for doctors, governments, patients on what to do about delisted ARVs

WHO issues guidance on what to do about delisted ARVs

Slow but real progress on antibodies against HIV

Viral load one month after starting HAART predicts who will be detectable after six months treatment

Therapy with an HIV vaccine: progress poor, prospects unclear

Increased risk of oral contraceptive failure with nelfinavir

Keeping viral load below 20,000 copies/ml still beneficial, even after HIV rebound

New antifungal provides new treatment option for oesophageal candidiasis

Injecting users may need to start treatment earlier than other HIV+ people, US study reports

Poor levels of T-20 seen in semen of HIV-positive men

HIV-positive gay men in Amsterdam often incorrectly perceive the level of their viral load; implications for safer sex

Increased risk of sudden cardiac death if erythromycin and protease inhibitors taken at same time

TB rates and mortality similar in HIV-1 and HIV-2 infected patients

Rethinking nevirapine revisited

Role for T-20 in pregnancy, says study

Receive the latest HIV research and conference news

Showing "11154" results for ""

International AIDS Vaccine Initiative abandons lead vaccine candidate, citing poor responses

Merck's Ad5 is AIDS vaccine most likely to test concept

Measles vaccine proposed for global AIDS protection

WHO issues guidance for doctors, governments, patients on what to do about delisted ARVs

WHO issues guidance on what to do about delisted ARVs

Slow but real progress on antibodies against HIV

Viral load one month after starting HAART predicts who will be detectable after six months treatment

Therapy with an HIV vaccine: progress poor, prospects unclear

Increased risk of oral contraceptive failure with nelfinavir

Keeping viral load below 20,000 copies/ml still beneficial, even after HIV rebound

New antifungal provides new treatment option for oesophageal candidiasis

Injecting users may need to start treatment earlier than other HIV+ people, US study reports

Poor levels of T-20 seen in semen of HIV-positive men

HIV-positive gay men in Amsterdam often incorrectly perceive the level of their viral load; implications for safer sex

Increased risk of sudden cardiac death if erythromycin and protease inhibitors taken at same time

TB rates and mortality similar in HIV-1 and HIV-2 infected patients

Rethinking nevirapine revisited

Role for T-20 in pregnancy, says study

Receive the latest HIV research and conference news